KC CARE Health Center-Clinical Trials ( Site 1422)

Kansas City, Missouri 64111

0 studies enrolling now · 1 studies all time

What they study most

HIV-1 Infection

Studies at this site

• A Switch to Doravirine/Islatravir (DOR/ISL) in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are Virologically Suppressed on Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) (MK-8591A-052) — Running, not enrolling